Key points are not available for this paper at this time.
Japan is a country with an approximate 10% prevalence rate of carbapenem-resistant
Yano et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: